(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 15.71 | 27.94 | 23.37 | -43.8% | -32.8% |
Total Expenses | 22.18 | 31.20 | 25.34 | -28.9% | -12.5% |
Profit Before Tax | -6.47 | -3.25 | -1.97 | 99.1% | 228.4% |
Tax | -2.33 | -0.45 | -0.44 | 417.8% | 429.5% |
Profit After Tax | -4.15 | -2.80 | -1.53 | 48.2% | 171.2% |
Earnings Per Share | -4.20 | -2.80 | -1.50 | 50.0% | 180.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Nureca Ltd is a company operating in the healthcare and wellness industry, specializing in the manufacturing and distribution of healthcare and wellness products. It provides a range of products, including medical devices, wellness products, and healthcare supplies, catering to both individual consumers and institutional clients. As of the latest available information, the company has been focusing on expanding its product offerings and increasing its market presence. However, specific recent developments or strategic initiatives undertaken by the company are not available in the provided data.
For the fourth quarter of fiscal year 2025 (Q4FY25), Nureca Ltd reported a total income of ₹15.71 crores. This represents a significant quarter-over-quarter (QoQ) decline of 43.8% compared to the total income of ₹27.94 crores recorded in the third quarter of fiscal year 2025 (Q3FY25). Additionally, the year-over-year (YoY) comparison with the fourth quarter of fiscal year 2024 (Q4FY24), where total income was ₹23.37 crores, shows a decrease of 32.8%. These figures suggest a substantial reduction in revenue during the most recent quarter.
In Q4FY25, Nureca Ltd reported a profit before tax (PBT) of -₹6.47 crores, which shows an increase in losses both QoQ and YoY. The PBT for Q3FY25 stood at -₹3.25 crores, marking a QoQ change of 99.1%. Compared to Q4FY24, where PBT was -₹1.97 crores, there is a YoY increase of 228.4% in losses. The profit after tax (PAT) for Q4FY25 was -₹4.15 crores, compared to -₹2.80 crores in Q3FY25, reflecting a QoQ change of 48.2%. YoY, the PAT has increased by 171.2% from -₹1.53 crores in Q4FY24. The company's earnings per share (EPS) also reflect similar trends, with Q4FY25 EPS at -₹4.20, compared to -₹2.80 in Q3FY25 and -₹1.50 in Q4FY24.
Nureca Ltd's total expenses for Q4FY25 were reported at ₹22.18 crores, showing a reduction of 28.9% QoQ from ₹31.20 crores in Q3FY25. The YoY comparison indicates a decrease of 12.5% from Q4FY24's total expenses of ₹25.34 crores. The tax expenses for Q4FY25 were -₹2.33 crores, compared to -₹0.45 crores in Q3FY25, reflecting a significant QoQ increase of 417.8%, and a YoY increase of 429.5% from -₹0.44 crores in Q4FY24. These figures highlight notable changes in the company's tax liabilities and overall expense management across quarters and years.